Omnicell OMCL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.36M— | —— | $5.46M-3.1% | $5.64M+180% | -$7.02M-144% | ||
| $18.57M-6.3% | $19.81M+2.1% | $19.4M-1.0% | $19.6M-2.0% | $20M+0.1% | ||
| $9.5M-20.7% | $11.98M+6.8% | $11.21M+6.5% | $10.53M-2.4% | $10.79M+19.3% | ||
| $4.23M+267% | -$2.53M-175% | $3.36M— | —— | -$3.84M+29.7% | ||
| $497K+0.2% | $496K-28.5% | $694K-4.4% | $726K-1.2% | $735K-15.6% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$122K-52.5% | -$80K+31.0% | -$116K+35.9% | -$181K-63.1% | -$111K+80.4% | ||
| -$1.7M— | —— | $1.8M-86.6% | $13.45M+442% | $2.48M+144% | ||
| $16.18M+181% | -$19.98M-333,067% | $6K-99.9% | $9.76M+948% | $931K-78.2% | ||
| -$292K+95.0% | -$5.9M— | $0+100% | -$16.26M-1,278% | $1.38M-80.2% | ||
| -$1.3M— | —— | -$1.24M+59.3% | -$3.03M-83.9% | -$1.65M-48.2% | ||
| $195K-77.4% | $863K+237% | $256K-34.2% | $389K+6.9% | $364K— | ||
| $40.28M— | —— | $11.8M— | —— | $20.18M+1,574% | ||
| -$57K-102% | $3.46M+183% | $1.22M-46.1% | $2.27M+181% | $809K+127% | ||
| $1.93M-2.2% | $1.97M+0.4% | $1.96M-4.7% | $2.06M+11.5% | $1.85M-17.7% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$2.97M-0.1% | -$2.97M-1.7% | -$2.92M+3.5% | -$3.03M-8.0% | -$2.8M-3.2% | ||
| $4.87M— | —— | $5.51M+390% | $1.13M-66.9% | $3.4M+446% | ||
| $33.3M+215% | -$28.97M— | —— | -$20.32M-266% | -$5.55M-190% | ||
| $54.5M+79.5% | $30.35M+7.4% | $28.27M-33.9% | $42.76M+64.9% | $25.92M-54.0% | ||
| $12.44M+61.3% | $7.71M-21.0% | $9.75M-17.2% | $11.78M+5.5% | $11.17M+22.9% | ||
| -$15.87M-10.0% | -$14.42M-1.0% | -$14.28M+10.3% | -$15.92M-1.2% | -$15.74M-16.0% | ||
| $7.76M+355% | $1.71M-75.3% | $6.9M— | $0-100% | $8.27M+2,950% | ||
| $2.6M+51.2% | $1.72M-34.1% | $2.61M+172% | $961K-59.8% | $2.39M+86.4% | ||
| $2.39M— | $0+100% | -$219.98M-1,818% | -$11.47M-384% | $4.04M+102% | ||
| -$1.09M-299% | $548K— | $0-100% | $1.74M+10.9% | $1.57M+160% | ||
| $39.93M— | —— | -$206.05M-1,305% | $17.1M+8.3% | $15.79M+108% | ||
| $497K+0.2% | $496K-28.5% | $694K-4.4% | $726K-1.2% | $735K-15.6% | ||
| -$122K-52.5% | -$80K+31.0% | -$116K+35.9% | -$181K-63.1% | -$111K+80.4% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $149.75K0.0% | $149.75K0.0% | $149.75K0.0% | $149.75K— | ||
| $33.3M+215% | -$28.97M— | —— | -$20.32M-266% | -$5.55M-190% | ||
| -$10.77M— | —— | -$2.4M— | —— | -$14.23M-194% | ||
| -$2.77M-136% | $7.68M+582% | $1.13M-22.4% | $1.45M+1,827% | -$84K-103% | ||
| -$2.97M-0.1% | -$2.97M-1.7% | -$2.92M+3.5% | -$3.03M-8.0% | -$2.8M-3.2% | ||
| $4.87M— | —— | $5.51M+390% | $1.13M-66.9% | $3.4M+446% | ||
| $195K-77.4% | $863K+237% | $256K-34.2% | $389K+6.9% | $364K— | ||
| $1.97M— | —— | —— | -$5.87M-289% | $3.1M-37.0% | ||
| -$57K-102% | $3.46M+183% | $1.22M-46.1% | $2.27M+181% | $809K+127% | ||
| $1.93M-2.2% | $1.97M+0.4% | $1.96M-4.7% | $2.06M+11.5% | $1.85M-17.7% | ||
| —— | $607.5K0.0% | $607.5K0.0% | $607.5K0.0% | $607.5K— | ||
| $3.43M-19.8% | $4.28M-5.5% | $4.53M+9.3% | $4.14M-9.3% | $4.57M+1.9% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $7.76M+355% | $1.71M-75.3% | $6.9M— | $0-100% | $8.27M+2,950% | ||
| -$2.77M-130% | $9.11M-28.2% | $12.68M+147% | $5.14M+380% | -$1.84M— | ||
| $180K-89.8% | $1.76M— | —— | —— | $976K+62.9% | ||
| $40.28M— | —— | $11.8M— | —— | $20.18M+1,574% | ||
| -$2.97M-0.1% | -$2.97M-1.7% | -$2.92M+3.5% | -$3.03M-8.0% | -$2.8M-3.2% | ||
| $42.07M+85.8% | $22.65M+22.3% | $18.51M-40.2% | $30.97M+110% | $14.75M-68.8% | ||
| $42.07M+85.8% | $22.65M+22.3% | $18.51M-40.2% | $30.97M+110% | $14.75M-68.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Omnicell generate?
- Omnicell (OMCL) generated $155.9M in operating cash flow over the trailing twelve months.
- What is Omnicell's free cash flow?
- After $41.7M of capital expenditures, Omnicell's free cash flow was $114.2M over the trailing twelve months, down 8.6% year over year.
- Where does Omnicell's cash flow data come from?
- Every line is extracted from Omnicell's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
